Skip to main content
logo
Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
10.09
+0.50 (5.21%)
Oct 19, 2026, 3:21 PM EDT - Market open

RGC Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Income
-11.7-3.58-4.3-5.87-7.45
Depreciation & Amortization
0.40.390.750.770.6
Loss (Gain) From Sale of Assets
---0-
Stock-Based Compensation
3.230.240.450.922.76
Other Operating Activities
-0.02-0.19-0.31-0.28-0.16
Change in Other Net Operating Assets
0.40.02-0.59-0.51-1.02
Operating Cash Flow
-7.7-3.11-4-4.96-5.27
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Capital Expenditures
--0.15-0.01-0.03-0.78
Sale of Property, Plant & Equipment
---0-
Investment in Securities
2.52.845.250.09-10
Investing Cash Flow
2.52.695.240.06-10.78

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Short-Term Debt Repaid
-----0.43
Total Debt Repaid
-----0.43
Net Debt Issued (Repaid)
-----0.43
Issuance of Common Stock
18.72---22.67
Repurchase of Common Stock
-1.78----
Other Financing Activities
--0.10.130.16
Financing Cash Flow
16.95-0.10.1322.41

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Foreign Exchange Rate Adjustments
0.02-0.110.05-0.08-
Net Cash Flow
11.77-0.541.4-4.856.36

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-7.7-3.27-4.01-4.99-6.05
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-0.02-0.01-0.01-0.01-0.01
Levered Free Cash Flow
-2.99-1.51-1.9-2.28-2.69
Unlevered Free Cash Flow
-2.99-1.51-1.9-2.28-2.69

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Change in Working Capital
0.40.02-0.59-0.51-1.02
SEC Filings: 10-K · 10-Q